Study Finds COVID-19 Virus Particles in Retinas of Infected, Deceased Patients
Previous research has shown that COVID-19 can impact ocular health.
Previous research has shown that COVID-19 can impact ocular health.
Sylvia Rosas, MD, MSCE, discusses highlights from the National Kidney Foundation’s Spring Clinical Meeting, including innovations in xenotransplantation, artificial intelligence, and the interplay between kidney,…
Swanpil Hiremath, MD, MPH, explains the importance of 24-hour ambulatory blood pressure monitoring (ABPM) to rule out the possibility of white coat hypertension.
Biologic therapy for psoriasis showed no significant impact on cardiovascular risk factors over one year in a retrospective study from Australia.
Within one month of treatment, anti-VEGF therapy improves anatomic and visual outcomes among eyes with stage 3 and 4 proliferative sickle cell retinopathy.
The CRL for the sBLA cites a lack of sufficient data to support the full evaluation of the effectiveness and safety of a 4-dose regimen…
These results may support clinical decision-making for psoriasis and nail psoriasis management and may allow future real-world studies to further understand the nature of this…
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care…
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care…
Two dermatologists and a patient discuss patient’s journey to the diagnosis of generalized pustular psoriasis (GPP) and its impact on the quality of life. They…
The FDA has extended the review period for palopegteriparatide in treatment of hyperparathyroidism in adult patients by 3 months to August 14, 2024.